Prediction of response to tapentadol in chronic low back pain

Manipulation of Neurotransmitter Levels Has Differential Effects on Formalin-Evoked Nociceptive Behavior in Male and Female Mice

(2016) Katherine A. Mifflin et al.   JOURNAL OF PAIN

Psychiatric Comorbidity Is Associated Prospectively with Diminished Opioid Analgesia and Increased Opioid Misuse in Patients with Chronic Low Back Pain

(2015) Ajay D. Wasan et al.   ANESTHESIOLOGY

Outcome Measures in Randomized-controlled Trials of Neuropathic Pain Conditions

(2015) Poonam Mehta et al.   CLINICAL JOURNAL OF PAIN

Statistical and data reporting guidelines for theEuropean Journal of Cardio-Thoracic Surgeryand theInteractive CardioVascular and Thoracic Surgery

(2015) Graeme L. Hickey et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?

(2015) P. Marchettini et al.   EUROPEAN JOURNAL OF PAIN

The influence of μ-opioid and noradrenaline reuptake inhibition in the modulation of pain responsive neurones in the central amygdala by tapentadol in rats with neuropathy

(2015) Leonor Gonçalves et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Effectiveness of Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR for the Management of Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-Label, Phase 3b/4 Study

(2015) Ralf Baron et al.   Pain Practice

The clinical course of low back pain: a meta-analysis comparing outcomes in randomised clinical trials (RCTs) and observational studies

(2014) Majid Artus et al.   BMC MUSCULOSKELETAL DISORDERS

Effectiveness and Tolerability of a Moderate Dose of Tapentadol Prolonged Release for Managing Severe, Chronic Low Back Pain with a Neuropathic Component: An Open-label Continuation Arm of a Randomized Phase 3b Study

(2014) Ralf Baron et al.   Pain Practice

Commentary on: Opioid and noradrenergic contributions of tapentadol in experimental neuropathic pain

(2013) Anthony H. Dickenson   NEUROSCIENCE LETTERS

Axial Low Back Pain: One Painful Area – Many Perceptions and Mechanisms

(2013) Matti Förster et al.   PLoS One

A systematic review of the global prevalence of low back pain

(2012) Damian Hoy et al.   ARTHRITIS AND RHEUMATISM

Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study

(2012) Ilona Steigerwald et al.   CURRENT MEDICAL RESEARCH AND OPINION

Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: a first step to a stratified treatment approach

(2012) Ralf Baron et al.   LANCET NEUROLOGY

Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations

(2012) Robert H. Dworkin et al.   PAIN

Relationship of Negative Affect and Outcome of an Opioid Therapy Trial Among Low Back Pain Patients

(2012) Robert N. Jamison et al.   Pain Practice

Tapentadol in Pain Management

(2011) Craig T. Hartrick et al.   CNS DRUGS

The Neuropathic Components of Chronic Low Back Pain: A Prospective Multicenter Study Using the DN4 Questionnaire

(2011) Nadine Attal et al.   JOURNAL OF PAIN

Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain

(2010) Bernd Lange et al.   ADVANCES IN THERAPY

Does Report of Craving Opioid Medication Predict Aberrant Drug Behavior Among Chronic Pain Patients?

(2009) Ajay D. Wasan et al.   CLINICAL JOURNAL OF PAIN